Is EPDPX or JNJ a better dividend investment in 2026?

EPDPX currently yields 5.68% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: EPDPX offers higher current income.

What is the dividend yield difference between EPDPX and JNJ?

EPDPX has a forward dividend yield of 5.68% ($0.85/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2.32 percentage points.

Home › Compare › EPDPX vs JNJ

EPDPX vs JNJ: Dividend Comparison 2026

EPDPX yields 5.68% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EPDPX wins by $12847.80M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EPDPX

● Live price

5.68%

Share price

$14.91

Annual div

$0.85

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$12847.82M

Annual income

$12,427,818,421.10

Full EPDPX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — EPDPX vs JNJ

📍 EPDPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EPDPX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EPDPX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EPDPX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPDPX

Annual income on $10K today (after 15% tax)

$483.17/yr

After 10yr DRIP, annual income (after tax)

$10,563,645,657.94/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, EPDPX beats the other by $10,563,644,954.32/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPDPX + JNJ for your $10,000?

EPDPX: 50%JNJ: 50%

100% JNJ50/50100% EPDPX

Portfolio after 10yr

$6423.92M

Annual income

$6,213,909,624.44/yr

Blended yield

96.73%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EPDPX

No analyst data

Altman Z

3.0

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPDPX buys

JNJ buys

No recent congressional trades found for EPDPX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEPDPXJNJ

Forward yield	5.68% ✓	3.36%
Annual dividend / share	$0.85	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	100% ✓	5.8%
Portfolio after 10y	$12847.82M ✓	$20.0K
Annual income after 10y	$12,427,818,421.10 ✓	$827.78
Total dividends collected	$12818.62M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EPDPX vs JNJ ($10,000, DRIP)

Year	EPDPX Portfolio	EPDPX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,837	$1,136.86	$10,676	$355.77	+$1.2K → EPDPX
2	$15,181	$2,515.30	$11,407	$389.39	+$3.8K → EPDPX
3	$22,273	$6,029.66	$12,198	$426.53	+$10.1K → EPDPX
4	$40,368	$16,535.83	$13,056	$467.62	+$27.3K → EPDPX
5	$99,212	$56,018.25	$13,987	$513.12	+$85.2K → EPDPX
6	$363,494	$257,337.31	$14,998	$563.56	+$348.5K → EPDPX
7	$2,151,248	$1,762,309.45	$16,098	$619.52	+$2.14M → EPDPX
8	$21,796,756	$19,494,920.82	$17,295	$681.69	+$21.78M → EPDPX
9	$392,528,781	$369,206,251.51	$18,599	$750.82	+$392.51M → EPDPX
10	$12,847,824,217	$12,427,818,421.10	$20,022	$827.78	+$12847.80M → EPDPX

EPDPX vs JNJ: Complete Analysis 2026

EPDPX — Stock

Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of dividend paying companies located in Europe or the Pacific Rim. It will invest primarily in non-U.S. companies. The fund may invest in companies of all capitalizations that the advisor considers to be attractive dividend paying companies.

Full EPDPX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this EPDPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPDPX vs SCHD EPDPX vs JEPI EPDPX vs O EPDPX vs KO EPDPX vs MAIN EPDPX vs ABBV EPDPX vs MRK EPDPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.